IGF1 and neoplasm: There is growing evidence of the role of IGF system dysregulation in endocrine neoplasms, and we will discuss the possible implications of these findings for tumor prevention and treatment, with a major focus on cancers from the thyroid, adrenal, and ovary, which are the most extensively studied.